Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors-Reference-Cited by-同舟云学术

Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors

Published:2006-01-16 Issue:1 Volume:5 Page:22-27
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Dahut William L.,Lakhani Nehal J.,Gulley James L.,Arlen Philip M.,Kohn Elise C.,Kotz Herbert,McNally Debbie,Parr Allyson,Parr Allyson,Nguyen Diana,Yang Sherry X.,Steinberg Seth M.,Venitz Jürgen,Sparreboom Alex,Figg, II William

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.4161/cbt.5.1.2349

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2-Methoxyestradiol, an Endogenous 17β-Estradiol Metabolite, Induces Antimitogenic and Apoptotic Actions in Oligodendroglial Precursor Cells and Triggers Endoreduplication via the p53 Pathway;Cells;2024-06-22

2. Rethinking the application of nanoparticles in women’s reproductive health and assisted reproduction;Nanomedicine;2024-05-21

3. 2-Methoxyestradiol and Hydrogen Peroxide as Promising Biomarkers in Parkinson’s Disease;Molecular Neurobiology;2023-08-17

4. 2-Methoxyestradiol-3,17-O,O-bis-sulfamate (STX140) Inhibits Proliferation and Invasion via Senescence Pathway Induction in Human BRAFi-Resistant Melanoma Cells;International Journal of Molecular Sciences;2023-07-11

5. Secreted Soluble Factors from Tumor-Activated Mesenchymal Stromal Cells Confer Platinum Chemoresistance to Ovarian Cancer Cells;International Journal of Molecular Sciences;2023-04-23